This event took place on Feb 05 2025
Gain more insight into the ISO 15189:2022 revisions by joining Angela Douglas, MBE, Deputy Chief Scientific Officer for NHS England, in this on-demand webinar as she breaks down the revised standard.
Webinar: Benefits of ISO 15189:2022 – an expert guide to adopting the revised standard
Discover more about ISO 15189 standard
About this webinar
In particular, this webinar focuses on how following this accreditation benefits pathology services, the intention of the revised ISO 15189 standard, the new terms and conditions and what they mean in practice.
Watch this webinar at any time to find out more about the revised standard and what it means in practice from an industry leaders.
This webinar is part of Ideagen's Life Sciences & Healthcare expert series.
key takeaways
What you will learn
- Understand ISO 15189:2022 revision from a leading pathologist’s perspective
- The benefits of following an accredited service in healthcare settings
- The intention of the revised ISO 15189:2022 standard
- New terms and definitions and what they mean for you in practice
Meet our speaker
Angela Douglas
Deputy Chief Scientific Officer, NHS EnglandAngela is a Consultant Clinical Scientist who has worked in the National Health Service (NHS) in genetics for over 38 years. In her role as Deputy Chief Scientific Officer for NHS England, she is partly responsible for the 50,000 healthcare scientists working in the NHS delivering high quality services for patients and people.
In 2016, Angela was commended in the Queen’s 90th birthday honors list as a Member of the Order of the British Empire for her contribution to research and mentoring students. “If I could change one thing, I would ensure that all healthcare science professionals had genomics and genetics included in their training,” says Angela.
Frequently asked questions
Simply register and you'll receive a link to watch it immediately.
Yes, you can pause and resume the webinar at your convenience.
Just a web browser! We’ll send you the link to access.